Enzo Veltri

2.4k total citations
13 papers, 421 citations indexed

About

Enzo Veltri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Enzo Veltri has authored 13 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Enzo Veltri's work include Lung Cancer Research Studies (5 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Enzo Veltri is often cited by papers focused on Lung Cancer Research Studies (5 papers), Cancer Treatment and Pharmacology (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Enzo Veltri collaborates with scholars based in Italy, Malaysia and United States. Enzo Veltri's co-authors include Cesare Gridelli, Ciro Gallo, Francesco Perrone, Vittorio Gebbia, S. Cigolari, Luigi Manzione, Giovanni Pietro Ianniello, Sergio Robbiati, Franco Vito Piantedosi and Santi Barbera and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

Enzo Veltri

13 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Enzo Veltri Italy	10	353	150	71	61	57	13	421
William Leslie United States	7	208 0.6×	98 0.7×	38 0.5×	54 0.9×	43 0.8×	17	314
Shiven B. Patel United States	12	276 0.8×	168 1.1×	106 1.5×	41 0.7×	36 0.6×	47	420
Sarah Caulfield United States	11	235 0.7×	163 1.1×	61 0.9×	36 0.6×	40 0.7×	42	353
Alfonso Illiano Italy	7	317 0.9×	299 2.0×	75 1.1×	108 1.8×	21 0.4×	9	469
Lydia Dreosti South Africa	10	300 0.8×	179 1.2×	157 2.2×	75 1.2×	27 0.5×	20	472
Jean-François Caubet United States	6	200 0.6×	255 1.7×	114 1.6×	44 0.7×	24 0.4×	8	473
Pauline du Rusquec France	10	225 0.6×	160 1.1×	93 1.3×	66 1.1×	19 0.3×	25	400
Kyrillus S. Shohdy Egypt	12	197 0.6×	213 1.4×	88 1.2×	114 1.9×	26 0.5×	39	440
Franco Vito Piantedosi Italy	12	519 1.5×	432 2.9×	92 1.3×	124 2.0×	76 1.3×	14	698
Deepa Rangachari United States	8	307 0.9×	179 1.2×	35 0.5×	51 0.8×	68 1.2×	13	360

Countries citing papers authored by Enzo Veltri

Since Specialization

Citations

This map shows the geographic impact of Enzo Veltri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enzo Veltri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enzo Veltri more than expected).

Fields of papers citing papers by Enzo Veltri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enzo Veltri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enzo Veltri. The network helps show where Enzo Veltri may publish in the future.

Co-authorship network of co-authors of Enzo Veltri

This figure shows the co-authorship network connecting the top 25 collaborators of Enzo Veltri. A scholar is included among the top collaborators of Enzo Veltri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enzo Veltri. Enzo Veltri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Graziano, Francesco, Annamaria Ruzzo, Eliana Rulli, et al.. (2016). Dihydropyrimidine dehydrogenase (DPYD) gene polymorphisms profiling in colon cancer patients treated with adjuvant chemotherapy in the randomized phase III TOSCA trial. Annals of Oncology. 27. iv1–iv1. 1 indexed citations

Rosti, Giovanni, Mario Petrini, Alberto Bosi, et al.. (2016). Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study. Therapeutic Advances in Medical Oncology. 9(1). 22–32. 9 indexed citations

Gamucci, Teresa, Andrea Michelotti, Laura Pizzuti, et al.. (2014). Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study. Journal of Cancer. 5(5). 320–327. 43 indexed citations

Zaniboni, Alberto, Enrico Aitini, Sandro Barni, et al.. (2012). FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study. Cancer Chemotherapy and Pharmacology. 69(6). 1641–1645. 65 indexed citations

Rossi, Luigi, Enzo Veltri, Angelo Zullo, et al.. (2012). Bevacizumab Plus Chemotherapy in Metastatic Colorectal Cancer Patients Treated in Clinical Practice. Future Oncology. 8(9). 1193–1197. 5 indexed citations

Salesi, Nello, et al.. (2012). Biosimilar Medicines in Oncology: Single-Center Experience with Biosimilar G-CSF. Future Oncology. 8(5). 625–630. 14 indexed citations

Maïo, Massimo Di, Cesare Gridelli, Ciro Gallo, et al.. (2005). Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials. The Lancet Oncology. 6(9). 669–677. 181 indexed citations

Salesi, Nello, Enzo Veltri, Barbara Di Cocco, et al.. (2005). Clinical experience with bevacizumab in colorectal cancer.. PubMed. 25(5). 3619–23. 12 indexed citations

Maïo, Massimo Di, Federica Perrone, Ciro Gallo, et al.. (2003). Supportive care in patients with advanced non-small-cell lung cancer. British Journal of Cancer. 89(6). 1013–1021. 19 indexed citations

10.

Gridelli, Cesare, L Brancaccio, Modesto DʼAprile, et al.. (2002). Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.. PubMed. 21(6A). 4179–83. 4 indexed citations

11.

Gridelli, Cesare, Luigi Manzione, Francesco Perrone, et al.. (2001). Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study. British Journal of Cancer. 84(1). 38–41. 14 indexed citations

12.

Gridelli, Cesare, Francesco Perrone, Giovanni Pietro Ianniello, et al.. (1998). Carboplatin plus vinorelbine, a new well-tolerated and active regimen for the treatment of extensive-stage small-cell lung cancer: a phase II study. Gruppo Oncologico Centro-Sud-Isole.. Journal of Clinical Oncology. 16(4). 1414–1419. 22 indexed citations

13.

Gridelli, Cesare, S. Palmeri, Modesto DʼAprile, et al.. (1996). Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. Annals of Oncology. 7(8). 821–826. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact